1,25-DIHYDROXYVITAMIN-D3 INHIBITS TRANSCRIPTION OF TYPE-I COLLAGEN GENES IN THE RAT OSTEO-SARCOMA CELL-LINE ROS 17/2.8
1,25-DIHYDROXYVITAMIN-D3 INHIBITS TRANSCRIPTION OF TYPE-I COLLAGEN GENES IN THE RAT OSTEO-SARCOMA CELL-LINE ROS 17/2.8
复制标题
DOI:
10.1210/endo-125-1-327
复制
发表时间:
1989-07-01
期刊:
影响因子:
4.8
通讯作者:
KREAM, BE
中科院分区:
文献类型:
--
作者:
HARRISON, JR;PETERSEN, DN;KREAM, BE
Our previous studies have demonstrated that 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3)] reduces type I collagen synthesis and steady state levels of procollagen mRNA in cultured fetal rat calvaria and rat osteosarcoma cells. To determine whether 1,25-(OH)2D3 regulates transcription of type I collagen genes, transcription rates were measured directly in nuclei isolated from ROS 17/2.8 cells using a nuclear run-off assay. Transcription was allowed to proceed in the presence of [32P]UTP for 20 min, at which time incorporation of radiolabeled UTP into trichloroacetic acid-precipitable material was maximal. UTP incorporation was inhibited 90% by 3 .mu.g/ml actinomycin-D and 40% by 1 .mu.g/ml .alpha.-amanitin. Treatment of ROS 17/2.8 cells with 1,25-(OH)2D3 inhibited procollagen gene transcription in a concentration and time dependent manner. Procollagen transcription was reduced by approximately 50% of the control rate by 10 nM 1,25-(OH)2D3, and this inhibition was maximal after 24 h of 1,25-(OH)2D3 treatment. The inhibition of procollagen transcription was specific for collagen, since total RNA synthesis and .beta.-actin transcription were not inhibited by 1,25-(OH)2D3. The magnitude of the decrease of procollagen transcription by 1,25-(OH)2D3 was comparable to its inhibition of steady state procollagen mRNA levels, suggesting that transcription is the predominant mechanism by which 1,25-(OH)2D3 regulates collagen gene expression in bone cells.